Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Proteon Thera Com ST (NASDAQ: PRTO)

$1.60 USD $0.05 (3.23%)
Last Price $1.6
Net Change $0.05 (3.23%)
Bid $0
Ask Price $2.45
Open Price $1.6
Previous Close Price $1.55
High Price $1.6
Low Price $1.55
Number of Trades 82
Volume 22,742
Fifty Two Week High $11.63 (2016-04-29)
Fifty Two Week Low $1.4 (2017-03-07)
Average Daily Volume 127,034
Share Outstanding 16,600 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $5.52
Recent Earnings $
Annual EPS $-1.73
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.509%
Annual Revenue $0B
No. Shares Outstanding 16,600
Inst. Shareholder % 42.47%
Annual Net Income $-0.03B
TTM Net Profit Margin $0
1-Year Return -78.14%
3-Year Return -84.55%
5-Year Return -84.55%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 5.52%
Dividends per Share $
Stock Split Ratio
Beta 1.61
Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201 a recombinant human elastase applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham Mass.

PRTO News & Stock Updates